Learn About Large-Cell Immunoblastic Lymphoma

What is the definition of Large-Cell Immunoblastic Lymphoma?
A diffuse large B-cell lymphoma characterized by the presence of immunoblasts with uniformly round-to-oval nuclei, a prominent nucleolus, and abundant cytoplasm.
Save information for later
Sign Up
What are the alternative names for Large-Cell Immunoblastic Lymphoma?
  • Lymphoma, large-cell, immunoblastic
  • Large cell immunoblastic lymphoma
Who are the top Large-Cell Immunoblastic Lymphoma Local Doctors?
AH
Alex F. Herrera
Dr. Alex F. Herrera
Hematology | Hematology Oncology
Elite
Highly rated in
27
conditions
Hematology
Hematology Oncology

City of Hope

City Of Hope - Duarte Main Campus

1500 E Duarte Rd, 
Duarte, CA 

Alex Herrera is a Hematologist and a Hematologist Oncology expert in Duarte, CA. Herrera has been practicing medicine for over 14 years and is rated as an Elite expert by MediFind in the treatment of Large-Cell Immunoblastic Lymphoma. He is also highly rated in 27 other conditions, according to our data. His top areas of expertise are Hodgkin Lymphoma, Classical Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Bone Marrow Transplant, and Bone Marrow Aspiration. He is board certified in American Board Of Internal Medicine, Hematology and American Board Of Internal Medicine, Oncology and licensed to treat patients in California. Herrera is currently accepting new patients.

TH
Dr. Thomas M. Habermann
Hematology | Oncology
Mayo Clinic - Minnesota
Elite
Highly rated in
38
conditions
Hematology
Oncology
Mayo Clinic - Minnesota

Mayo Clinic

Mayo Clinic - Minnesota

200 1st St Sw, 
Rochester, MN 

Thomas Habermann is a Hematologist and an Oncologist in Rochester, Minnesota. Habermann has been practicing medicine for over 44 years and is rated as an Elite expert by MediFind in the treatment of Large-Cell Immunoblastic Lymphoma. He is also highly rated in 38 other conditions, according to our data. His top areas of expertise are Diffuse Large B-Cell Lymphoma (DLBCL), Follicular Lymphoma, Non-Hodgkin Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration. He is licensed to treat patients in Minnesota. Habermann is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn more
JA
James O. Armitage
Dr. James O. Armitage
Hematology | Oncology | Hematology Oncology
Elite
Highly rated in
28
conditions
Hematology
Oncology
Hematology Oncology

Nebraska Medicine

Cancer Center At Village Pointe Health Center

111 N 175th St, 
Omaha, NE 

James Armitage is a Hematologist and an Oncologist in Omaha, Nebraska. Armitage has been practicing medicine for over 50 years and is rated as an Elite expert by MediFind in the treatment of Large-Cell Immunoblastic Lymphoma. He is also highly rated in 28 other conditions, according to our data. His top areas of expertise are Diffuse Large B-Cell Lymphoma (DLBCL), Non-Hodgkin Lymphoma, B-Cell Lymphoma, Bone Marrow Transplant, and Endoscopy. He is licensed to treat patients in Nebraska. Armitage is currently accepting new patients.

View All Doctors
What are the latest Large-Cell Immunoblastic Lymphoma Clinical Trials?
Phase I Trial of Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated Lymphomas
Enrollment Status: Recruiting
Publish Date: December 15, 2022
Intervention Type: Drug
Study Phase: Phase 1

Background: Non-Hodgkin lymphoma (NHL) is the most common cancer among people living with HIV in the United States. People with HIV are up to 17 times more likely to get NHL than people who do not have HIV. The disease may also be different in these two groups. More study is needed for treating people with both HIV and NHL.

Match to trials
Find the right clinical trials for you in under a minute
Get started
Phase II Study of Dose-Adjusted EPOCH+/-Rituximab in Adults With Untreated Burkitt Lymphoma, c-MYC Positive Diffuse Large B-Cell Lymphoma and Plasmablastic Lymphoma
Who is this study for: Adult patients with diffuse large B-cell lymphoma and other lymphomas
Enrollment Status: Active, not recruiting
Publish Date: November 09, 2022
Intervention Type: Drug
Study Phase: Phase 2

Background: Burkitt lymphoma/leukemia (BL) is highly treatable, but most of the standard therapies require multiple doses of intensive chemotherapy that may require long hospital stays and frequently have severe side effects. In addition, BL is a fairly common type of cancer in patients who also have human immunodeficiency virus (HIV), but treatment outcomes are poor because standard treatments do not work ve...

View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center

What are the Latest Advances for Large-Cell Immunoblastic Lymphoma?

There is no recent research available for this condition. Please check back because thousands of new papers are published every week and we strive to find and display the most recent relevant research as soon as it is available.